Back to search
Plague, Pneumonic
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Plague, Pneumonic trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Plague, Pneumonic trials you may qualify forThis study will evaluate the immunogenicity, safety, and tolerability of rF1V-1018 vaccine
The goal of this clinical trial is to learn if a single dose of the study drug, JST-010, is safe and tolerable when administered by injection into the arm or th…
This study is being done to learn more about the disease in Ituri and to evaluate a new rapid test that may help doctors find the disease more quickly. This res…
Phase 2, Randomized, Active-Controlled, Observer-Blinded, Multicenter Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine with CpG 1018® Adjuv…
The primary objective of this trial is to test the hypothesis that ciprofloxacin monotherapy given (orally, intravenously, or combination) for 10 days is non-in…